Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related Diseases

NCT05757804 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT05757804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05757804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related Diseases
Lead sponsor
Huashan Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 17, 2023
Completion date
January 14, 2024
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alpha synuclein pathology, positron-emission tomography